{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:55:48Z","timestamp":1790002548348,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cyto.2019.154789","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T18:31:17Z","timestamp":1564079477000},"page":"154789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p"],"prefix":"10.1016","volume":"123","author":[{"given":"Amanda","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio S.","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Wilhelmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Still","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Petrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn S.","family":"Gerhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna K.","family":"DiStefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.cyto.2019.154789_b0005","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cyto.2019.154789_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease","volume":"8","author":"McCullough","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2036.2008.03710.x","article-title":"Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"28","author":"Younossi","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.cyto.2019.154789_b0020","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.cyto.2019.154789_b0025","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1111\/liv.12523","article-title":"Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?","volume":"34","author":"Tariq","year":"2014","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.cyto.2019.154789_b0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/apt.13376","article-title":"Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease","volume":"42","author":"Wieland","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.cyto.2019.154789_b0035","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"Miura","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cyto.2019.154789_b0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2019.154789_b0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","article-title":"Chemokines and disease","volume":"2","author":"Gerard","year":"2001","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2019.154789_b0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","article-title":"Chemokines in liver inflammation and fibrosis","volume":"30","author":"Wasmuth","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"10.1016\/j.cyto.2019.154789_b0055","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cyto.2019.154789_b0060","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"Seki","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22952","article-title":"CCR2 promotes hepatic fibrosis in mice","volume":"50","author":"Seki","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.cyto.2019.154789_b0075","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","article-title":"CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis","volume":"63","author":"Affo","year":"2014","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cyto.2019.154789_b0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v21.i2.475","article-title":"Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition","volume":"21","author":"Hou","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/sji.12367","article-title":"CCL20-CCR6 cytokine network facilitate Treg activity in advanced grades and metastatic variants of hepatocellular carcinoma","volume":"83","author":"Li","year":"2016","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2019.154789_b0090","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-3083.2006.001766.x","article-title":"Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma","volume":"63","author":"Rubie","year":"2006","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2019.154789_b0095","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.5301\/JBM.2012.9097","article-title":"The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma","volume":"27","author":"Soliman","year":"2012","journal-title":"Int. J. Biol. Mark."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12967-018-1490-y","article-title":"CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading","volume":"16","author":"Chu","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2019.154789_b0105","doi-asserted-by":"crossref","first-page":"850246","DOI":"10.1155\/2015\/850246","article-title":"Nonalcoholic steatohepatitis: involvement of the telomerase and proinflammatory mediators","volume":"2015","author":"Serhal","year":"2015","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0014-4827(85)90243-5","article-title":"Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver","volume":"160","author":"Hendriks","year":"1985","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.cyto.2019.154789_b0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1210\/js.2018-00122","article-title":"Transcriptomic profiling of obesity-related nonalcoholic steatohepatitis reveals a core set of fibrosis-specific genes","volume":"2","author":"Gerhard","year":"2018","journal-title":"J. Endocr. Soc."},{"issue":"2","key":"10.1016\/j.cyto.2019.154789_b0125","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: Precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"issue":"6","key":"10.1016\/j.cyto.2019.154789_b0130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1472-6947-12-45","article-title":"An electronic health record-enabled obesity database","volume":"12","author":"Wood","year":"2012","journal-title":"BMC Med. Inf. Decis. Mak."},{"issue":"3","key":"10.1016\/j.cyto.2019.154789_b0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.trsl.2015.04.014","article-title":"High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis","volume":"166","author":"Leti","year":"2015","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.cyto.2019.154789_b0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00592-014-0654-3","article-title":"Genome-wide analysis of hepatic lipid content in extreme obesity","volume":"52","author":"DiStefano","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.cyto.2019.154789_b0150","doi-asserted-by":"crossref","first-page":"368210","DOI":"10.1155\/2014\/368210","article-title":"Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity","volume":"2014","author":"Gerhard","year":"2014","journal-title":"J. Obes."},{"issue":"22","key":"10.1016\/j.cyto.2019.154789_b0155","doi-asserted-by":"crossref","first-page":"11673","DOI":"10.1093\/nar\/gks901","article-title":"MiRmap: comprehensive prediction of microRNA target repression strength","volume":"40","author":"Vejnar","year":"2012","journal-title":"Nucl. Acids Res."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.cyto.2019.154789_b0170","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/ndt\/gfm365","article-title":"High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism","volume":"22","author":"Qi","year":"2007","journal-title":"Nephrol. Dial. Transp."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canlet.2011.10.031","article-title":"miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells","volume":"316","author":"Vicinus","year":"2012","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.cyto.2019.154789_b0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.trsl.2015.04.014","article-title":"High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis","volume":"166","author":"Leti","year":"2015","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.cyto.2019.154789_b0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","article-title":"Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease","volume":"52","author":"Leamy","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.cyto.2019.154789_b0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gutjnl-2011-301146","article-title":"Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis","volume":"62","author":"Affo","year":"2013","journal-title":"Gut"},{"issue":"415 Suppl","key":"10.1016\/j.cyto.2019.154789_b0195","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.blo0000093845.72468.bd","article-title":"Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis","author":"Choong","year":"2003","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"10.1016\/j.cyto.2019.154789_b0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.cyto.2019.154789_b0205","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/db09-1403","article-title":"C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis","volume":"59","author":"Obstfeld","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.cyto.2019.154789_b0210","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/db11-1506","article-title":"CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1\/M2 status","volume":"61","author":"Kitade","year":"2012","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.cyto.2019.154789_b0215","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/CIRCULATIONAHA.106.638379","article-title":"T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity","volume":"115","author":"Wu","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cyto.2019.154789_b0220","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cyto.2019.154789_b0225","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2013-09-527739","article-title":"MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma","volume":"123","author":"Ito","year":"2014","journal-title":"Blood"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619302182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619302182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:55:36Z","timestamp":1760907336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619302182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":45,"alternative-id":["S1043466619302182"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154789","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154789"}}